Publication
Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
dc.contributor.author | Estarreja, João | |
dc.contributor.author | Mendes, Priscila | |
dc.contributor.author | Silva, Carina | |
dc.contributor.author | Camacho, Pedro | |
dc.contributor.author | Mateus, Vanessa | |
dc.date.accessioned | 2023-12-17T18:17:55Z | |
dc.date.available | 2023-12-17T18:17:55Z | |
dc.date.issued | 2023-12 | |
dc.description.abstract | [This corrects the article DOI: 10.2196/38658.] | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Estarreja J, Mendes P, Silva C, Camacho P, Mateus V. Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis. JMIR Res Protoc. 2023;12:e50411. | pt_PT |
dc.identifier.doi | 10.2196/50411 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.21/16721 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.relation.publisherversion | https://preprints.jmir.org/preprint/50411 | pt_PT |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | pt_PT |
dc.subject | Ophthalmology | pt_PT |
dc.subject | Age-related macular degeneration | pt_PT |
dc.subject | Bevacizumab | pt_PT |
dc.subject | Drug therapy | pt_PT |
dc.subject | nAMD | pt_PT |
dc.subject | Neovascular age-related macular degeneration | pt_PT |
dc.subject | Wet macular degeneration | pt_PT |
dc.title | Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.startPage | e50411 | pt_PT |
oaire.citation.title | JMIR Research Protocols | pt_PT |
oaire.citation.volume | 12 | pt_PT |
person.familyName | Estarreja | |
person.familyName | Rodrigues Gomes Mendes | |
person.familyName | Silva | |
person.familyName | Camacho | |
person.familyName | Pinho Mateus | |
person.givenName | João | |
person.givenName | Priscila | |
person.givenName | Carina | |
person.givenName | Pedro | |
person.givenName | Vanessa Alexandra | |
person.identifier.ciencia-id | EB19-EDA2-704B | |
person.identifier.ciencia-id | 6A16-5C18-F10B | |
person.identifier.ciencia-id | 2411-5936-0820 | |
person.identifier.ciencia-id | 271F-B4E1-014E | |
person.identifier.ciencia-id | 5A12-571D-AD6A | |
person.identifier.orcid | 0000-0002-8283-3174 | |
person.identifier.orcid | 0000-0002-0013-3140 | |
person.identifier.orcid | 0000-0003-1021-7935 | |
person.identifier.orcid | 0000-0002-2986-5652 | |
person.identifier.orcid | 0000-0002-3204-3772 | |
person.identifier.scopus-author-id | 55258764900 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | d16a20d0-ac73-4989-b83d-abeab53139f7 | |
relation.isAuthorOfPublication | b02faa18-658e-4edc-b846-7c0b3646414c | |
relation.isAuthorOfPublication | 81a5cd80-1982-43ba-bde5-4c43ae0e5234 | |
relation.isAuthorOfPublication | c41e9c52-157e-4375-8005-b609cfc374e7 | |
relation.isAuthorOfPublication | 406041a5-682c-4f94-a4e2-ddbfc541313c | |
relation.isAuthorOfPublication.latestForDiscovery | c41e9c52-157e-4375-8005-b609cfc374e7 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Correction_The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration_protocol for a systematic review and meta-analysis.pdf
- Size:
- 20.19 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: